Horizons Marijuana Life Sciences Index ETF

In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.

This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.

AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.

Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.

On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.

Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]

Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.

The reason cannabis stocks are rising could be because October 17 is approaching.

Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.

Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?

The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.

Today, Planet 13 Holdings (PNTH) (PLNHF) announced that it had inked a purchase agreement with Tyson Ranch, which is owned by boxer Mike Tyson.

Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

The spotlight is on marijuana legalization as the demand keeps surging. More states have stepped up to legalize either recreational or medical cannabis.

So far, cannabis stocks have rebounded in 2020, which investors expected. The marijuana industry struggled in 2019. Overall, the rebound will take time.

Cronos Group and Aphria are Jim Cramer’s top picks in the cannabis sector. Aphria’s upbeat earnings results restored investors’ faith in the sector.

Earlier this week, Rahul Sarugaser of Raymond James upgraded Cronos Group (NASDAQ:CRON) from “market perform” to “outperform.”

On Monday, HEXO announced that it received a license amendment from Health Canada for its manufacturing and processing facility in Belleville, Ontario.

Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.

As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.

Acquisitions could boost Curaleaf’s production and retail footprint significantly. With the EBITDA expected to rise over the next two years, there’s significant upside.

Today, Aurora Cannabis (ACB) was trading 11.2% higher at 12:06 PM ET. The company had lost 63.3% of its stock value YTD as of Monday.

Donald Trump has never openly supported marijuana legalization, and this month, Trump has shared some conflicting views on medical marijuana legalization.

Warren Buffett is one of the greatest value investors in the world. He’s invested in companies across various sectors, but he’s avoided cannabis. Why?

Recreational marijuana is now legal in Michigan. It took the step in 2018, but the licensing process and regulations took awhile.

Jim Cramer expressed disappointment with the cannabis industry, claiming it may not be the “incredible opportunity” he thought it was.

Cowen & Co. increased its estimates for the US cannabis market, expecting $85 billion in sales by 2030. Its previous sales forecast was $80 billion.

Cannabis is an evolving sector. Recently, Warren Buffett entered the space following Kraft Heinz’s (KHC) newest investment in Flowhub.

After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.

As of October 4, Aurora Cannabis was trading at a forward EV-to-EBITDA multiple of 33.05x compared to 68.8x at the beginning of September.

Aurora Cannabis posted its fourth-quarter earnings after the market closed on Wednesday. The company posted revenues of 98.9 million Canadian dollars.

Aurora Cannabis (ACB) stock has been rising before its fourth-quarter earnings on Thursday. The stock has risen 12.4% this month.

HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.

CannTrust (CTST) was hit with selling pressure this morning as its stock declined almost 5%. However, the overall cannabis sector seems to be positive

Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.

On Monday morning, OrganiGram’s third-quarter earnings came in as a bit of a let-down. Here’s why.

Tilray (TLRY) is turning out to be one of the worst performers among the cannabis sector players with a YTD loss of 16%.

On April 3, Georgia’s state assembly approved a bill to legalize the production and sale of marijuana, which will be strictly for medicinal purposes.

In the second quarter, HEXO (HEXO) had total assets of 446 million Canadian dollars, which increased year-over-year from 334 million Canadian dollars.

Buffett sees companies as businesses and not just tickers. Buffett avoids businesses that he doesn’t understand.

In the first half of January 14, Tilray (TLRY) was up 6.8% as of noon. The stock continued its upward momentum after it received a boost last week.

The Investment Industry Regulatory Organization of Canada imposed a trading halt on Canopy Growth at 4:11 PM EST on February 16, 2018.